rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ronald Lee Bowman

Chief Human Resources Officer

Company insider

Files Form 4 as: Chief Human Resources Officer, QuidelOrtho.

In numbers

Trades disclosed
22
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
15 Sep 2024
Last trade
15 Sep 2026
Last filed
17 Sep 2026

Companies traded

Where they are an officer
QDEL QuidelOrthoOfficer · Diagnostics & Labs · last 15 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Sep 2026filed 17 Sep 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code M—2,566 at $0.00filing
15 Sep 2026filed 17 Sep 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code F$9,790921 at $10.63filing
15 Sep 2026filed 17 Sep 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,566 at $0.00filing
15 Sep 2026filed 17 Sep 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,566 at $0.00filing
15 Sep 2026filed 17 Sep 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code M—2,566 at $0.00filing
15 Sep 2026filed 17 Sep 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code F$9,790921 at $10.63filing
30 Jan 2026filed 3 Feb 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—36,152 at $0.00filing
30 Jan 2026filed 3 Feb 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—36,150 at $0.00filing
30 Jan 2026filed 3 Feb 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—36,152 at $0.00filing
30 Jan 2026filed 3 Feb 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—36,150 at $0.00filing
29 Jan 2026filed 2 Feb 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—2,938 at $0.00filing
29 Jan 2026filed 2 Feb 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code F$33K1,210 at $27.41filing
29 Jan 2026filed 2 Feb 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,938 at $0.00filing
29 Jan 2026filed 2 Feb 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,938 at $0.00filing
29 Jan 2026filed 2 Feb 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—2,938 at $0.00filing
29 Jan 2026filed 2 Feb 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code F$33K1,210 at $27.41filing
15 Sep 2025filed 17 Sep 2025QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,565 at $0.00filing
15 Sep 2025filed 17 Sep 2025QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—2,565 at $0.00filing
15 Sep 2025filed 17 Sep 2025QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code F$27K918 at $28.92filing
29 Jan 2025filed 31 Jan 2025QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—8,816 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Bryan Michael HansonEVP Global Port. Mgmt & Mkting · EVP Global Port. Mgmt & Mkting at QuidelOrtho, filing Form 4 there in the last year
Micah W. YoungChief Financial Officer · Chief Financial Officer at QuidelOrtho, filing Form 4 there in the last year
Kenneth F. BuechlerDirector · Director at QuidelOrtho, filing Form 4 there in the last year
Ann D. RhoadsDirector · Director at QuidelOrtho, filing Form 4 there in the last year
R. Scott HuennekensDirector · Director at QuidelOrtho, filing Form 4 there in the last year